Lumipulse G sTREM2 assay

ST2 enzyme-linked immunoassay kit for quantitative measurement of soluble growth stimulating expressed gene 2 protein in serum or plasma samples. Used for cardiac risk stratification, heart failure prognosis, and inflammatory disease assessment in clinical laboratories. Provides reliable immunoassay results with standardized ELISA methodology.

A diagnostic test kit for measuring soluble growth stimulation expression gene 2 protein using fluorescence immunochromatography. It is used for in vitro diagnostic testing in clinical laboratory settings.

Chemiluminescence immunoassay for quantitative measurement of inflammatory markers. Included in the company's extensive chemiluminescence product line of over 70 registered assays. Supports clinical inflammation assessment and monitoring.

Chemiluminescent immunoassay kit for detecting neurofilament protein biomarkers associated with Alzheimer's disease. Enables early diagnosis and disease monitoring in clinical laboratory settings. Provides quantitative measurement with high sensitivity and specificity for neurodegenerative disease assessment.

A multiplex blood test kit for traumatic brain injury diagnosis utilizing GFAP and UCH-L1 biomarkers. The assay enables rapid and accurate detection of mild traumatic brain injury including concussion using magnetic particles of varying lengths.

Rapid blood-based assay for traumatic brain injury diagnosis using dual biomarkers (GFAP and UCH-L1) with magnetic particle immunoassay technology. Delivers results in 15-50 minutes on a fully automated platform, enabling quick and accurate detection of brain concussions and traumatic brain injuries in clinical settings.

A multiplex assay for research use only (RUO) designed to quantitatively detect and measure two neurological biomarkers: glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase-L1 (UCH-L1) in human samples. The assay can be used with serum (recommended), plasma, or cell culture supernatates for research applications in stroke, Alzheimer's disease, Parkinson's disease, and other neurological conditions. This product is not intended for traumatic brain injury (TBI) diagnostic use.

An in vitro diagnostic immunochromatographic lateral-flow assay for the semi-quantitative measurement of human soluble Toll-like receptor 2 (sTLR2) in plasma, used as a biomarker for sepsis and other inflammatory conditions. The test delivers results in 10 minutes from a 20µL plasma or serum sample. Each kit contains 10 test devices and uses proprietary sTLR2 monoclonal antibodies. The assay is UKCA certified for clinical use in Great Britain and is developed and manufactured in the UK according to ISO13485 quality standards.

A multiplex assay for research use only (RUO) designed to quantitatively detect and measure three neurological biomarkers: phosphorylated tau 181 (pTau 181), phosphorylated tau 231 (pTau 231), and total tau in human samples. The assay has dynamic ranges of 2.5 pg/ml to 320 pg/ml for pTau variants and 0.625 pg/ml to 160 pg/ml for total tau. It can be used with serum (recommended), plasma, or cell culture supernatates for Alzheimer's disease and other neurodegenerative disease research.

A multiplex assay for research use only (RUO) designed to quantitatively detect and measure glial fibrillary acidic protein (GFAP) biomarker in human samples. The assay has a dynamic range of 3.125 pg/ml to 400 pg/ml with a limit of detection of 0.384 pg/ml. It can be used with serum (recommended), plasma, or cell culture supernatates for neurological disease research applications.

A multiplex assay for research use only (RUO) designed to quantitatively detect and measure neurofilament light chain (NfL) biomarker in human samples. The assay has a dynamic range of 1.25 pg/ml to 640 pg/ml with a limit of detection of 0.47 pg/ml. It can be used with plasma (recommended), serum, or cell culture supernatates for neurological disease research applications including Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions.

An immunochromatographic lateral-flow assay for semi-quantitative measurement of soluble Toll-like receptor 2 in plasma or serum. The test provides results within 10 minutes and helps diagnose sepsis and inflammatory conditions. Each kit contains 10 test devices with proprietary monoclonal antibodies for sTLR2 detection.